Adaptive Biotechnologies Corporation (MUN:1HM)
13.88
-0.18 (-1.28%)
At close: Jan 9, 2026
Adaptive Biotechnologies Revenue
Adaptive Biotechnologies had revenue of $93.97M USD in the quarter ending September 30, 2025, with 102.38% growth. This brings the company's revenue in the last twelve months to $252.75M, up 42.57% year-over-year. In the year 2024, Adaptive Biotechnologies had annual revenue of $178.96M with 5.10% growth.
Revenue (ttm)
$252.75M
Revenue Growth
+42.57%
P/S Ratio
11.04
Revenue / Employee
$408.33K
Employees
619
Market Cap
2.38B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 178.96M | 8.68M | 5.10% |
| Dec 31, 2023 | 170.28M | -15.03M | -8.11% |
| Dec 31, 2022 | 185.31M | 30.96M | 20.06% |
| Dec 31, 2021 | 154.34M | 55.96M | 56.88% |
| Dec 31, 2020 | 98.38M | 13.31M | 15.65% |
| Dec 31, 2019 | 85.07M | 29.41M | 52.83% |
| Dec 31, 2018 | 55.66M | 17.22M | 44.77% |
| Dec 31, 2017 | 38.45M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kulmbacher Brauerei Aktien-Gesellschaft | 294.43M |
| MHP Hotel AG | 161.04M |
| Hoftex Group AG | 141.95M |
| BAVARIA Industries Group AG | 140.95M |
| Gesundheitswelt Chiemgau AG | 78.15M |
| Allgäuer Brauhaus AG | 39.94M |
| Landshuter Kunstmuehle AG | 24.18M |
| Münchener Tierpark Hellabrunn AG | 17.46M |
Adaptive Biotechnologies News
- 19 days ago - What's Going On With Adaptive Biotechnologies Shares Tuesday? - Benzinga
- 19 days ago - Adaptive Biotechnologies Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
- 19 days ago - Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 20 days ago - Adaptive Biotechnologies Rises 10% As Revenue Surges Over 50% - Nasdaq
- 20 days ago - Adaptive Biotechnologies (ADPT) Surpasses Q4 Revenue Estimates, Shares Climb - GuruFocus
- 20 days ago - Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 23 days ago - Insider Sell: Harlan Robins Sells Shares of Adaptive Biotechnologies Corp - GuruFocus
- 24 days ago - Chad Robins Sells 124,998 Shares of Adaptive Biotechnologies Corp - GuruFocus